Generation Healthy Kids: A Cluster-randomized Trial of a Multi-component, Multi-setting Intervention (GHK)

November 20, 2025 updated by: University of Copenhagen

Generation Healthy Kids: A Cluster-randomized Trial of a Multi-component, Multi-setting Intervention to Promote Healthy Weight and Wellbeing in Danish School-aged Children

The GHK intervention was developed according to the United Kingdom Medical Research Council's framework for developing and evaluating complex interventions. A pilot- and feasibility study was conducted during December 2022-April 2023, and the intervention was subsequently adapted and adjusted.

The GHK main trial is a two-school-year cluster-randomized school- and community trial designed to investigate the effect of the multi-setting, multi-component GHK intervention program on weight development, health and wellbeing in Danish children aged 6-11 years. The trial will include 24 schools in Denmark (12 intervention and 12 control).

The primary aim of the cluster-randomized trial is to investigate whether the GHK intervention program can promote healthy body composition as measured by fat mass (FM) in the intervention group compared with the control group. We hypothesize that the intervention will result in less FM gain in the intervention group compared with the control group over the two school-year study period.

Study Overview

Detailed Description

Generation Healthy Kids is a cluster-randomized school and community trial in which 24 schools will be randomly allocated to intervention or control. Schools are evenly distributed in two areas of Denmark: DK-EAST (Capital Region of Denmark and Region Zealand) and DK-WEST (Region of Southern Denmark). The overall study objective is to investigate if a 2-school-year multi-setting, multi-component intervention focusing on healthy diets, physical activity, sleep and screen media habits in the school and local community can promote healthy weight and body composition in children who are in 1st and 2nd grade at inclusion (i.e., age 6-9 years at inclusion). We will also investigate the intervention's effects on dietary intake and nutritional status; food literacy; family- and school meal culture, physical literacy, activity levels, and fitness; sleep and screen media habits; growth; cardio metabolic health; cognitive and motor functions; school performance; and mental health and well-being. Furthermore, we will evaluate the context, implementation and working mechanisms of the intervention.

In continuation of the above, we will investigate if the intervention can reduce social inequality in the outcomes, as well as explore potential effect modifiers such as sex, ethnicity, implementation levels, genetics, epigenetics etc. We will also explore associations between sociodemographic characteristics, health behaviors and outcomes cross-sectionally and longitudinally and use these data to validate and compare relevant measurement tools.

The innovative aspects of the Generation Healthy Kids study are the combination of an intervention targeting several important risk factors for excessive weight gain (dietary habits, physical activity, sleep, and screen time) with community capacity building and a systems approach. The unique combination is closely monitored for effect as well as process. The integrated intervention program will be distinctive in combining already tested effective intervention strategies with intervention components developed using co-creation and a systems mapping and working in varying settings of the child's life. Systems thinking will furthermore be used to ensure that a health equity lens is employed to understand the relationship between obesity and health inequalities locally. To reach children and families with low socio-economic status, focus will be on developing interventions that make healthy choices easy by creating healthy environments around the children, both at school and during leisure time.

Study Type

Interventional

Enrollment (Actual)

1372

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Capital Region and Region Zealand
      • Copenhagen, Capital Region and Region Zealand, Denmark
        • 11 schools in the Capital Region of Denmark and Region Zealand
    • Region Syddanmark
      • Odense, Region Syddanmark, Denmark, 5230
        • 12 Schools in Region of Southern Denmark

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • All children attending 1st or 2nd grade in the recruited schools

Exclusion Criteria:

- No exclusion criteria will be applied. If parents, teachers or research staff judge that a child cannot participate in certain parts of the intervention or measurement schedule, e.g. due to severe allergies, chronic diseases or mental/physical disabilities, the child will be eligible to participate in the remaining parts of the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Generation Healthy Kids intervention
The intervention focuses on food and nutrition, physical activity, sleep and screen media habits, and engagement of the local stakeholders.
A key element is that children receive a free of charge healthy do-it-yourself school lunch 4 days per week. The meals adhere to the Nordic Nutrition Recommendations and the Danish Food-Based Dietary Guidelines with focus on fish, wholegrains, fruits and vegetables and drinking water as well as stimulation of children's food literacy. Other intervention components involve the after school clubs, local retail stores and the parents.
To ensure that all children reach the recommended 3x30 minutes of vigorous activity per week, we will implement three weekly 40-minute sessions in the school curriculum. These sessions will be carried out throughout the study period and will encompass modified and varied sporting activities and games, which promote motivation, physical literacy, active involvement of all children, and high training intensity.
The aim of this component is to promote healthy sleep and screen media behaviours. Sleep and screen media recommendations will be presented for parents at three parent workshops and in electronic infographics. Teachers/pedagogues will facilitate small assignments on screen media and sleep practices with children during school time. Children will talk about and reflect upon screen media and sleep practices in their family, based on assignments and material from e.g., Medierådet (The Danish Media Council). The results of the children's assignments will be presented to their parents at later workshops. This is done to integrate the children's perspective in the parent workshops, especially in relation to screen media habits.
Community capacity building in selected local communities. To promote healthier eating, children and families need to be supported within their local community by food environments that make the healthy choice the easy choice and not a challenge in their everyday life. To promote physical activity, the children will be invited to participate in activities in the local sports clubs including camps in the holidays.
No Intervention: Control
The schools will continue with their regular school schedules.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fat mass in kg
Time Frame: Baseline and 18-20 months
Between group difference in change in fat mass measured by bioimpedance analysis (InBody 270).
Baseline and 18-20 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fat mass in kg (2)
Time Frame: Baseline , 6-8 months, 18-20 months
Between group difference in change in fat mass measured by a bioimpedance analysis (InBody 270).
Baseline , 6-8 months, 18-20 months
Height in cm
Time Frame: Baseline , 6-8 months, 18-20 months
Between group difference in change in standing height measured using a portable stadiometer.
Baseline , 6-8 months, 18-20 months
Weight status in %
Time Frame: Baseline , 6-8 months, 18-20 months
Between group difference in change in prevalence of children with underweight, normalweight, overweight and obesity, based on the cutoffs defined by Cole et al. and the International Task Force of Obesity. Body weight is measured by a bioimpedance analysis (InBody 270) and height by using a portable stadiometer.
Baseline , 6-8 months, 18-20 months
BMI z-score
Time Frame: Baseline , 6-8 months, 18-20 months
Between group difference in change in BMI z-score based on WHO references. Weight and height is measured using weight from the bioimpedance analysis (InBody 270) and a portable stadiometer, respectively.
Baseline , 6-8 months, 18-20 months
Waist circumference in mm
Time Frame: Baseline , 6-8 months, 18-20 months
Between group difference in change in waist circumference to the nearest mm by a non-elastic measuring tape at the level of the umbilicus.
Baseline , 6-8 months, 18-20 months
Fat free mass in kg
Time Frame: Baseline , 6-8 months, 18-20 months
Between group difference in change in fat free mass measured by a bioimpedance analysis (InBody 270).
Baseline , 6-8 months, 18-20 months
Fat mass index in kg/m2
Time Frame: Baseline , 6-8 months, 18-20 months
Between group difference in change in fat mass index measured by a bioimpedance analysis (InBody 270).
Baseline , 6-8 months, 18-20 months
Fat free mass index in kg/m2
Time Frame: Baseline , 6-8 months, 18-20 months
Between group difference in change in fat free mass index measured by a bioimpedance analysis (InBody 270).
Baseline , 6-8 months, 18-20 months
Fat-Free-Mass-to-Fat-Mass ratio
Time Frame: Baseline , 6-8 months, 18-20 months
Between group difference in change in FFM-to-FM ratio measured by a bioimpedance analysis (InBody 270).
Baseline , 6-8 months, 18-20 months
% Fat Mass
Time Frame: Baseline , 6-8 months, 18-20 months
Between group difference in change in % FM in kg measured by a bioimpedance analysis (InBody 270).
Baseline , 6-8 months, 18-20 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Health related quality of life
Time Frame: Baseline , 6-8 months, 18-20 months
Between group difference in change in the total summary score of health-related quality of life measured with the KIDSCREEN 27 child self-report questionnaire. Data is collected using an adapted video and speech assisted electronic version with a smiley scale for each answer. The questionnaire assesses the child's physical well-being (5 items), psychological well-being (7 items), autonomy and parent relation (7 items), peers and social support (4 items), and school environment (4 items).
Baseline , 6-8 months, 18-20 months
Mental health
Time Frame: Baseline , 6-8 months, 18-20 months
Between group difference in change in the total difficulties score of the Strengths and difficulties questionnaire. Assessed using the parent-reported version of the Strengths and Difficulties Questionnaire. An overall total difficulties score is calculated, along with five subscale scores: emotional symptoms, conduct problems, hyperactivity/Inattention, relationship problems, and prosocial behavior.
Baseline , 6-8 months, 18-20 months
Resting blood pressure in mmHg
Time Frame: Baseline , 6-8 months, 18-20 months
Between group difference in change in systolic and diastolic blood pressure.
Baseline , 6-8 months, 18-20 months
Resting heart rate beats/min
Time Frame: Baseline , 6-8 months, 18-20 months
Between group difference in change in heart rate.
Baseline , 6-8 months, 18-20 months
Plasma lipid profile in mmol/L
Time Frame: Baseline and 6-8 months, (18-20 months if funding is available)
Between group difference in change in plasma total, LDL and HDL cholesterol and triacylglycerol. Only among children in DK-EAST.
Baseline and 6-8 months, (18-20 months if funding is available)
Plasma insulin in pmol/L.
Time Frame: Baseline and 6-8 months, (18-20 months if funding is available)
Between group difference in change in plasma insulin. Only among children in DK-EAST.
Baseline and 6-8 months, (18-20 months if funding is available)
Plasma glucose in mmol/L.
Time Frame: Baseline and 6-8 months, (18-20 months if funding is available)
Between group difference in change in plasma glucose. Only among children in DK-EAST.
Baseline and 6-8 months, (18-20 months if funding is available)
Aerobic fitness and intermittent exercise performance
Time Frame: Baseline, 6-8 months, 18-20 months
Between group difference in change in aerobic fitness and intermittent exercise performance.
Baseline, 6-8 months, 18-20 months
Sprint performance
Time Frame: Baseline, 6-8 months, 18-20 months
Between group difference in change in sprint performance as measured by 20 m sprint test.
Baseline, 6-8 months, 18-20 months
Muscular fitness and strength
Time Frame: Baseline, 6-8 months, 18-20 months
Between group difference in change in muscular fitness and strength.
Baseline, 6-8 months, 18-20 months
Balance ability
Time Frame: Baseline and 18-20 months
Between group difference in change in balance ability.
Baseline and 18-20 months
Jump height
Time Frame: Baseline and 18-20 months
Between group difference in change in jump height (countermovement jump).
Baseline and 18-20 months
Upper and lower extremity gross motor function
Time Frame: Baseline and 18-20 months
Between group difference in change in Upper and lower extremity gross motor function.
Baseline and 18-20 months
Agility
Time Frame: Baseline and 18-20 months
Between group difference in change in agility will be assessed using the Canadian Exercise and Movement Skills Assessment (CAMSA)
Baseline and 18-20 months
Physically active behavior
Time Frame: Baseline, 18-20 months
Between group change in total time spent being physical active. Non-sedentary time is defined as any waking activity characterized as not being in a sitting, reclining or lying posture with minimal stationary movement. Activity is measured for 7 consecutive days using a thigh worn accelerometer (Axivity AX3).
Baseline, 18-20 months
Moderate to vigorous physical activity
Time Frame: Baseline, 18-20 months
Between group change in time spent in moderate to vigorous physical activity. Moderate to vigorous physical activity is measured for 7 consecutive days using a thigh worn accelerometer (Axivity AX3).
Baseline, 18-20 months
Total sleep time
Time Frame: Baseline, 18-20 months
Between group change in total sleep time. Sleep is measured for 7 consecutive days using a thigh worn accelerometer (Axivity AX3).
Baseline, 18-20 months
Sleep quality
Time Frame: Baseline , 6-8 months, 18-20 months
Between group difference in change in sleep quality, as measured by Child Sleep Habits Questionnaire (parent-reported).
Baseline , 6-8 months, 18-20 months
Total screen time
Time Frame: Baseline , 6-8 months, 18-20 months
Between group difference in change in total screen time (hours), as measured by modified SCREENS questionnaire (parent-reported).
Baseline , 6-8 months, 18-20 months
Smartphone and tablet usage
Time Frame: Baseline , 6-8 months, 18-20 months
Between group difference in change in smartphone/tablet usage, objectively assessed over 14 days using Ethica application.
Baseline , 6-8 months, 18-20 months
Food literacy
Time Frame: Baseline, 6-8 months, 18-20 months
Between group difference in change in child-reported using a GHK food literacy and meal culture questionnaire currently under development
Baseline, 6-8 months, 18-20 months
School meal culture
Time Frame: Baseline, 6-8 months, 18-20 months
Between group difference in change in child-reported using a GHK food literacy and meal culture questionnaire currently under development
Baseline, 6-8 months, 18-20 months
Family meal culture
Time Frame: Baseline, 6-8 months, 18-20 months
Between group difference in change in child-reported using a GHK food literacy and meal culture questionnaire currently under development
Baseline, 6-8 months, 18-20 months
Dietary intake in g/day
Time Frame: Baseline, 6-8 months, 18-20 months
Between group difference in change in dietary intake by 3-day electronic dietary record and FFQ.
Baseline, 6-8 months, 18-20 months
n-3 long-chain polyunsaturated fatty acid (LCPUFA) status in weight%
Time Frame: Baseline and 6-8 months, (18-20 months if funding is available)
Between group difference change in wholeblood n-3 LCPUFA status (eicosapentaenoic acid and docosahexaenoic acid). Only among children in DK-EAST.
Baseline and 6-8 months, (18-20 months if funding is available)
Blood hemoglobin in mmol/L.
Time Frame: Baseline and 6-8 months, (18-20 months if funding is available)
Between group difference in change in wholeblood hemoglobin (iron status). Only among children in DK-EAST.
Baseline and 6-8 months, (18-20 months if funding is available)
Serum ferritin in ug/L.
Time Frame: Baseline and 6-8 months, (18-20 months if funding is available)
Between group difference in change in serum ferritin (iron status). Only among children in DK-EAST.
Baseline and 6-8 months, (18-20 months if funding is available)
Serum 25-hydroxyvitamin D in nmol/L.
Time Frame: Baseline and 6-8 months, (18-20 months if funding is available)
Between group difference in change in serum 25-hydroxyvitamin D (vitamin D status). Only among children in DK-EAST.
Baseline and 6-8 months, (18-20 months if funding is available)
Insulin-like growth factor-1 in ug/L.
Time Frame: Baseline and 6-8 months, (18-20 months if funding is available)
Between group difference in change in serum insulin-like growth factor-1 (growth factor). Only among children in DK-EAST.
Baseline and 6-8 months, (18-20 months if funding is available)
Processing speed
Time Frame: Baseline and 18-20 months
Performance in neuropsychological assessment of processing speed as choice reaction time (Cambridge Neuropsychological Test Automated Battery, Cambridge cognition, UK).
Baseline and 18-20 months
Sustained attention
Time Frame: Baseline and 18-20 months
Performance in neuropsychological assessment of sustained attention ability assessed as errors during a sustained test procedure (Cambridge Neuropsychological Test Automated Battery, Cambridge cognition, UK).
Baseline and 18-20 months
Spatial working memory
Time Frame: Baseline and 18-20 months
Performance in neuropsychological assessment of spatial working memory assessed as errors and strategy during the test procedure (Cambridge Neuropsychological Test Automated Battery, Cambridge cognition, UK).
Baseline and 18-20 months
Inhibitory control
Time Frame: Baseline and 18-20 months
Performance in neuropsychological assessment of inhibitory control assessed as errors during the test procedure (Cambridge Neuropsychological Test Automated Battery, Cambridge cognition, UK).
Baseline and 18-20 months
Cognitive flexibility
Time Frame: Baseline and 18-20 months
Performance in neuropsychological assessment of cognitive flexibility assessed as errors during the test procedure (Cambridge Neuropsychological Test Automated Battery, Cambridge cognition, UK).
Baseline and 18-20 months
Fine motor control
Time Frame: Baseline and 18-20 months
Performance in neuropsychological assessment of fine motor control assessed as endpoint accuracy during the test procedure (Cambridge Neuropsychological Test Automated Battery, Cambridge cognition, UK).
Baseline and 18-20 months
School performance - Danish reading comprehension
Time Frame: Baseline and 18-20 months
Between group difference in change in Danish reading skills (Hogrefe, Denmark).
Baseline and 18-20 months
School performance - mathematics proficiency
Time Frame: Baseline and 18-20 months
Between group difference in change in mathematics proficiency (Hogrefe, Denmark).
Baseline and 18-20 months
School absence due to sickness and other causes
Time Frame: Baseline, 6-8 months, 18-20 months
Between group difference in change in number of days abscent from school due to sickness recorded in school registration data
Baseline, 6-8 months, 18-20 months
Physical literacy
Time Frame: Baseline, 18-20 months
Between group difference in change in total score of physical literacy as well as for the emotional, cognitive and physical subdomain
Baseline, 18-20 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Nikolai B Nordsborg, PhD, University of Copenhagen
  • Principal Investigator: Jens Troelsen, PhD, University of Southern Denmark
  • Study Chair: Ulla Toft, PhD, Capitol Region of Southern Denmark

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 14, 2023

Primary Completion (Actual)

June 30, 2025

Study Completion (Actual)

June 30, 2025

Study Registration Dates

First Submitted

July 4, 2023

First Submitted That Met QC Criteria

July 4, 2023

First Posted (Actual)

July 11, 2023

Study Record Updates

Last Update Posted (Actual)

November 26, 2025

Last Update Submitted That Met QC Criteria

November 20, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Only de-indentified data will be shared.

IPD Sharing Access Criteria

A formal application must be approved by the study's steering committee.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sleep

Clinical Trials on Food and Nutrition

Subscribe